Listing & Compliance Notices

HUMANIGEN, INC received a nasdaq delisting notice notice regarding market value.

“April 5, 2023, prior to the Hearing, the Company received a letter from the Nasdaq Staff notifying the Company that it had not regained compliance with the minimum MVLS requirement as of April 3, 2023 and that this deficiency would serve as an additional basis for delisting the Company’s securities from Nasdaq. The Nasdaq Staff’s letter also informed the Company that the Panel would consider, and the Company should address, this additional deficiency at the Hearing. At the Hearing held before the Panel on April 6, 2023, the Company outlined its plans for regaining compliance with the minimum b”

Oncternal Therapeutics, Inc. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2)).

“April 4, 2023, Oncternal Therapeutics, Inc. (“Oncternal”) received a letter from the Nasdaq staff indicating that, for the last thirty consecutive business days, the bid price for Oncternal’s common stock had closed below the minimum $1.00 per share requirement for continued listing on The Nasdaq Capital Market under Nasdaq Listing Rule 5550(a)(2). In accordance with Nasdaq Listing Rule 5810(c)(3)(A), Oncternal has been provided an initial period of 180 calendar days, or until October 2, 2023, to regain compliance. The letter states that the Nasdaq staff will provide written notification that”

CHEMBIO DIAGNOSTICS, INC. received a nasdaq delisting notice notice regarding minimum bid price (rules 5550(a)).

“April 6, 2023, Chembio Diagnostics, Inc. (the “Company”) received formal notice from the Listing Qualifications Staff (the “Staff”) of The Nasdaq Stock Market LLC (“Nasdaq”) indicating that the Company’s continued non-compliance with the minimum bid price requirement set forth in Nasdaq Listing Rule 5550(a) (the “Bid Price Rule”) would result in the delisting of the Company’s securities from Nasdaq unless the Company timely requests a hearing before the Nasdaq Hearings Panel (the “Panel”). The Company intends to timely request a hearing before the Panel, which request will stay any further a”

ARROW FINANCIAL CORP received a nasdaq deficiency notice notice regarding late filing (rules 5250(c)(1)).

“April 3, 2023, Arrow Financial Corporation (the “ Company ”) received a notice from the Listing Qualifications Department of The NASDAQ Stock Market LLC (“ Nasdaq ”) that the Company is noncompliant with the periodic filing requirements for continued listing set forth in Nasdaq Listing Rule 5250(c)(1) (the “ Rule ”) as a result of its failure to file its Annual Report on Form 10-K for the year ended December 31, 2022 (the “ Untimely Form 10-K ”) with the Securities and Exchange Commission (the “ SEC ”) by the required due date (the “ Nasdaq Notice ”). As previously reported by the Company in i”

GRAPHJET TECHNOLOGY received a nasdaq deficiency notice notice regarding market value (rules 5450(b)(2)(A), 5810(c)(3)(A)).

“March 31, 2023, Energem Corp. (the “ Company ”) received a notice (the “ MVLS Notice ”) from the Nasdaq Stock Market LLC (“ Nasdaq ”), stating that the Company’s listed securities failed to comply with the $50 million minimum market value of listed securities (“ Market Value of Listed Securities ”) requirement for continued listing on The Nasdaq Global Market in accordance with Nasdaq Listing Rule 5450(b)(2)(A) based upon the Company’s Market Value of Listed Securities for the 30 consecutive business days prior to the date of the MVLS Notice. The MLVS Notice has no immediate effect on the list”

Kairous Acquisition Corp. Ltd received a nasdaq deficiency notice notice regarding market value (rules 5450(b)(2)(A)).

“April 3, 2023, Kairous Acquisition Corp. Limited (the “Company”) received a written notification from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”). The notification indicated that the Company did not meet the $50,000,000 minimum market value of listed securities (“MVLS”) required to maintain continued listing as set forth in Nasdaq Marketplace Rule 5450(b)(2)(A) for the 30-business day period ended March 31, 2023. Under applicable Nasdaq rules, the Company will have 180 calendar days from the date of the notification, or until October 2, 2023, to regain compl”

Intelligent Medicine Acquisition Corp. received a nasdaq noncompliance notice notice regarding other (rules 5450(b)(2)(B)).

“March 30, 2023, Intelligent Medicine Acquisition Corp. (the “Company”) received a letter (the “Letter”) from the Listing Qualifications division (the “Staff”) of the Nasdaq Stock Market LLC (“Nasdaq”) stating that the Company has not paid certain fees required by Nasdaq Listing Rule 5250(f) and that the Company will be delisted unless it appeals such determination. As of the date of the Notice, the Company’s past due fee balance totaled $140,000. If the Company elects not to appeal, trading of its Class A ordinary shares will be suspended at the opening of business on April 11, 2023 and a Form”

Intelligent Medicine Acquisition Corp. received a nasdaq deficiency notice notice regarding other (rules 5250(f), 5450(b)(2)(B), 5810(c)(2)(A)).

“March 30, 2023, Intelligent Medicine Acquisition Corp. (the “Company”) received a letter (the “Letter”) from the Listing Qualifications division (the “Staff”) of the Nasdaq Stock Market LLC (“Nasdaq”) stating that the Company has not paid certain fees required by Nasdaq Listing Rule 5250(f) and that the Company will be delisted unless it appeals such determination. As of the date of the Notice, the Company’s past due fee balance totaled $140,000. If the Company elects not to appeal, trading of its Class A ordinary shares will be suspended at the opening of business on April 11, 2023 and a Form”

Estrella Immunopharma, Inc. received a nasdaq deficiency notice notice regarding market value (rules 5550(b)(2)).

“April 3, 2023, TradeUP Acquisition Corp. (the “Company”) received a written notice (the “Notice”) from the listing qualifications department staff of The Nasdaq Stock Market (“Nasdaq”) notifying the Company that for the last 30 consecutive business days, the Company’s minimum Market Value of Listed Securities (“MVLS”) was below the minimum of $35 million required for continued listing on the Nasdaq Capital Market pursuant to Nasdaq Listing Rule 5550(b)(2) (the “Market Value Standard”). The Notice is only a notification of deficiency, not of imminent delisting, and has no current effect on the”

Atlantic Coastal Acquisition Corp. received a nasdaq deficiency notice notice regarding audit committee (rules 5605, 5605(b)(1)(A), 5605(c)(4)).

“April 3, 2023, the Company received notice (“Notice”) from the Nasdaq Stock Market LLC (“Nasdaq”) informing the Company that, as a result of Mr. Tapiero’s resignation, the Company was not in compliance with Nasdaq’s listing rules (the “Listing Rules”) as set forth in Listing Rule 5605 given the Company’s failure to adhere to the independent director, audit, and compensation committee requirements. Consistent with Listing Rules 5605(b)(1)(A) and 5605(c)(4), the Company has until the earlier of the Company’s next annual shareholders’ meeting or March 21, 2024 to regain compliance. However, if th”

Spectral AI, Inc. received a nasdaq deficiency notice notice regarding market value (rules 5550(b)(2), 5550(b)(1), 5550(b)(3)).

“April 3, 2023, Rosecliff Acquisition Corp I (the “Company”) received a written notice (the “Notice”) from the Listing Qualifications Department (the “Staff”) of The Nasdaq Stock Market (“Nasdaq”) indicating that the Company is not in compliance with Listing Rule 5550(b)(2), due to the Company’s failure to meet the minimum $35 million Market Value of Listed Securities (“MVLS”) requirement for the Nasdaq Capital Market. The Staff based the review of the Company’s MVLS on the last 30 consecutive business days (February 17, 2023 to March 31, 2023) and determined a deficiency exists with regards”

Tattooed Chef, Inc. received a nasdaq deficiency notice notice regarding late filing (rules 5250(c)(1)).

“March 31, 2023, Tattooed Chef, Inc. (the “Company”) received notice from The Nasdaq Stock Market, LLC (“Nasdaq”) indicating that the Company was not in compliance with Nasdaq Listing Rule 5250(c)(1), which requires listed companies to timely file all required periodic financial reports with the Securities and Exchange Commission (“SEC”), due to the Company’s failure to timely file its Annual Report on Form 10-K for the fiscal year ended December 31, 2022 (the “Form 10-K”). The notification letter has no immediate effect on the listing or trading of the Company’s common stock on the Nasdaq Capi”

Digital Media Solutions, Inc. received a nyse noncompliance notice notice regarding minimum bid price (rules 802.01C).

“March 30, 2023, the Company received notice from the New York Stock Exchange (the "NYSE") indicating that the Company is not in compliance with Rule 802.01C of the NYSE’s Listed Company Manual (“Rule 802.01C”) because the average closing price of the Company's Class A common stock was less than $1.00 over a consecutive 30 trading-day period. Under Rule 802.01C, the Company has a period of six months from receipt of the notice to regain compliance with the NYSE minimum stock price listing requirement. The Company has notified the NYSE of its intent to cure the stock price deficiency and return”

Motus GI Holdings, Inc. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2)).

“March 31, 2023, Motus GI Holdings, Inc. (the “Company”) received a written notice (the “Notice”) from the Listing Qualifications Department of The Nasdaq Stock Market (“Nasdaq”) indicating that the Company is not in compliance with the $1.00 Minimum Bid Price requirement set forth in Nasdaq Listing Rule 5550(a)(2) for continued listing on The Nasdaq Capital Market (the “Bid Price Requirement”). The Notice does not result in the immediate delisting of the Company’s common stock from The Nasdaq Capital Market. The Nasdaq Listing Rules require listed securities to maintain a minimum bid price of”

authID Inc. received a nasdaq deficiency notice notice regarding stockholders equity (rules 5550(b)(1)).

“April 4, 2023, the Company received a notice letter from the Listing Qualifications staff of The NASDAQ Stock Market LLC (“Nasdaq”) indicating that the Company was not in compliance with Nasdaq Listing Rule 5550(b)(1) (“Rule 5550(b)(1)”) as the Company’s stockholders’ equity of $283,536, as reported on the Company’s Annual Report on Form 10-K for the period ended December 31, 2022, was below $2.5 million, which is the minimum stockholders’ equity required for compliance with Rule 5550(b)(1). Further, as of April 3, 2023, the Company did not meet the alternative compliance standards relating to”

Tailwind International Acquisition Corp. received a nyse delisting notice notice regarding market value (rules 802.01B).

“value $0.00001 per share, that are listed to trade on NYSE under the symbol “TWNI” (the “Ordinary Shares”). Trading in the Units and Ordinary Shares was suspended immediately. NYSE determined to delist the Units and Ordinary Shares due to the Company’s inability to meet the requirements of Section 802.01B of the NYSE’s Listed Company Manual that requires a listed acquisition company to maintain an average aggregate global market capitalization attributable to its publicly held shares over a consecutive 30 trading day period of at least $40,000,000. The Company does not intend to appeal the NY”

Fathom Digital Manufacturing Corp received a nyse deficiency notice notice regarding minimum bid price (rules 802.01C).

“March 29, 2023, Fathom Digital Manufacturing Corporation (the “Company”) was notified by the New York Stock Exchange (the “NYSE”) that the average closing price of the Company’s Class A common stock, par value $0.0001 per share (the “Common Stock”), over the prior 30 consecutive trading day period was below $1.00 per share, which is the minimum average closing price per share required to maintain listing on the NYSE under Section 802.01C of the NYSE Listed Company Manual (“Section 802.01C”). Under Section 802.01C, the Company has a period of six months following the receipt of the notice to re”

Boxed, Inc. received a nyse delisting notice notice regarding other (rules 802.01D).

“April 3, 2023, the New York Stock Exchange (the “NYSE”) notified Boxed, Inc. (the “Company”) that the NYSE determined to commence proceedings to delist the Company’s common stock, $0.0001 par value per share, from the NYSE and that trading in the Company’s common stock would be suspended immediately, pursuant to Section 802.01D of the NYSE Listed Company Manual after the Company filed voluntary petitions for relief under Chapter 11 of the U.S. Bankruptcy Code in the U.S. Bankruptcy Court for the District of Delaware on April 2, 2023. The NYSE issued a press release stating the foregoing on A”

ATOSSA THERAPEUTICS, INC. received a nasdaq extension granted notice regarding minimum bid price (rules 5550(a)(2)).

“April 4, 2023, the Company was informed that the deadline for compliance was extended by 180 days, or until October 2, 2023. The October 5, 2022 NASDAQ notice of noncompliance has no immediate effect on the listing or trading of the Company’s common stock on the NASDAQ Stock Market. The Company intends to actively monitor the bid price for its common stock between now and October 2, 2023, and will consider available options to resolve the deficiency and regain compliance with the minimum bid price requirement, including, if necessary, effectuating a reverse stock split. . * * * SIGNATURES Purs”

Tonix Pharmaceuticals Holding Corp. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2)).

“March 31, 2023, Tonix Pharmaceuticals Holding Corp. (the “Company”) received a letter (the “Notice”) from the Listing Qualifications staff of The Nasdaq Stock Market LLC (“Nasdaq”) indicating that, based upon the closing bid price of the Company’s common stock for the last 30 consecutive business days, the Company no longer meets the requirement to maintain a minimum bid price of $1 per share, as set forth in Nasdaq Listing Rule 5550(a)(2) (the “Minimum Bid Price Requirement”). In accordance with Nasdaq listing rules, the Company has been provided a period of 180 calendar days, or until Septem”

DXP ENTERPRISES INC received a nasdaq deficiency notice notice regarding late filing (rules 5250(c)(1)).

“April 3, 2023, the Company received a written notice (the “Notice”) from the Listing Qualifications Department of The Nasdaq Stock Market (“Nasdaq”) stating that the Company is not in compliance with Nasdaq Listing Rule 5250(c)(1) (the “Rule”) because it has not timely filed the Form 10-K with the SEC. The Rule requires listed companies to timely file all required periodic reports with the SEC. The Notice has no immediate effect on the listing or trading of the Company’s securities. However, if the Company fails to timely regain compliance with the Rule, the Company’s securities will be subjec”

ENERGY FOCUS, INC/DE received a nasdaq delisting notice notice regarding minimum bid price (rules 5550(a)(2), 5810(c)(2)(A)).

“March 28, 2023, the Company received written notification (the “Additional Staff Determination”) from the Staff stating that (i) following the Bid Price Notification, and in accordance with Listing Rule 5810(c)(2)(A), Nasdaq is no longer permitted to consider the Plan, (ii) the Additional Staff Determination serves as an additional basis for delisting the Company’s common stock from Nasdaq and (iii) the Panel will consider the Additional Staff Determination in rendering a determination regarding the continued listing of the Company’s common stock on Nasdaq. The Company intends to diligently pu”

ENERGY FOCUS, INC/DE received a nasdaq deficiency notice notice regarding stockholders equity (rules 5550(b)(1)).

“November 16, 2022, the Company received a written notification from the Listing Qualifications staff (the “Staff”) of The Nasdaq Stock Market (“Nasdaq”) that the Company is not in compliance with the minimum stockholders’ equity requirement for continued listing on the Nasdaq Capital Market. Nasdaq Listing Rule 5550(b)(1) requires listed companies to maintain stockholders’ equity of at least $2,500,000 (the “Stockholders’ Equity Requirement”). The Company’s Form 10-Q for the Quarterly Period Ended September 30, 2022 filed on November 10, 2022 reflected that the Company’s stockholders’ equity a”

SEP Acquisition Corp. received a nasdaq deficiency notice notice regarding market value (rules 5550(b)(2), 5810(c)(3)(C)).

“March 28, 2023, SEP Acquisition Corp. (the “Company”) received a written notice (the “Notice”) from the listing qualifications department staff of The Nasdaq Stock Market (“Nasdaq”) notifying the Company that for the last 30 consecutive business days, the Company’s minimum Market Value of Listed Securities (“MVLS”) was below the minimum of $35 million required for continued listing on the Nasdaq Capital Market pursuant to Nasdaq Listing Rule 5550(b)(2) (the “Market Value Standard”). The Notice is only a notification of deficiency, not of imminent delisting, and has no current effect on the lis”

Sunlight Financial Holdings Inc. received a nyse noncompliance notice notice regarding late filing (rules 802.01E).

“April 3, 2023 the Company was notified by NYSE that it is not in compliance with Section 802.01E of the NYSE Listed Company Manual, which requires that NYSE-listed companies timely file all periodic reports with the SEC. Sunlight is currently finalizing the 10-K to incorporate recent developments, including the Commitment & Transaction Support Agreement, and expects to file the 10-K with the SEC in the first half of April 2023, significantly prior to the end of the six-month cure period to file the 10-K as provided by Section 802.01E of the NYSE Listed Company Manual. During this time, the Com”

Sunlight Financial Holdings Inc. received a nyse noncompliance notice notice regarding minimum bid price (rules 802.01C).

“March 31, 2023, the Company was notified by the New York Stock Exchange (“NYSE”) that the Company is not in compliance with the continued listing standard contained in Rule 802.01C of the NYSE’s Listed Company Manual (“Rule 802.01C”) relating to the minimum average closing price of the Common Stock, required over a consecutive 30 trading-day period. The notice does not result in the immediate delisting of the Company’s Common Stock from the NYSE. The Company intends to notify the NYSE within 10 business days of its intent to regain compliance with Rule 802.01C. The Company expects to regain co”

Charah Solutions, Inc. received a nyse delisting notice notice regarding market value (rules 802.01B).

“April 3, 2023, Charah Solutions, Inc. (the “Company”) was notified by the New York Stock Exchange (“NYSE”) that, due to the Company’s failure to maintain an average global market capitalization over a consecutive 30-day trading period of at least $15 million, pursuant to Section 802.01B of the NYSE Listed Company Manual, the NYSE had determined to commence proceedings to delist the Company’s common stock and 8.5% Senior Notes due 2026 (the “Notes” and, together with the Company’s common stock, the “Securities”) from the NYSE. Trading of the Company’s Securities was suspended effective as of ap”

Hyzon Motors Inc. received a nasdaq deficiency notice notice regarding late filing (rules 5250(c)(1)).

“ed the Company a 15-calendar day stay of delisting, and subsequently granted the Company’s request for a stay pending the hearing. The delisting hearing was held on March 16, 2023 before the Hearings Panel. At the hearing, the Company presented its plan to regain compliance with Nasdaq Listing Rule 5250(c)(1) (the “Periodic Filing Rule”), and requested the continued listing of its securities on The Nasdaq Capital Market pending such compliance. On March 31, 2023, the Company received a letter from the Hearings Panel indicating that the Hearings Panel granted the Company’s request for continued”

Rubicon Technologies, Inc. received a nyse deficiency notice notice regarding minimum bid price (rules 802.01C).

“March 28, 2023, Rubicon Technologies, Inc. (the “Company”) received notice (the “Notice”) from the New York Stock Exchange (the “NYSE”) that the average per share trading price of its Class A common stock (the “Common Stock”) was below the NYSE’s continued listing standard rule relating to minimum average share price. Rule 802.01C of the NYSE’s Listed Company Manual requires that a company’s common stock trade at a minimum average closing price of $1.00 over a consecutive 30 trading-day period. Pursuant to Section 802.01C, the Company has a period of six months following the receipt of the Not”

Longevity Health Holdings, Inc. received a nasdaq deficiency notice notice regarding other (rules 5550(a)(3)).

“March 29, 2023, Alpha Healthcare Acquisition Corp. III (the “ Company ”) received a written notice (the “ Notice ”) from the Nasdaq Listing Qualifications Department of The Nasdaq Stock Market (“ Nasdaq ”) indicating that the Company was not in compliance with Listing Rule 5550(a)(3), which requires the Company to have at least 300 public holders for continued listing on the Nasdaq Capital Market (the “ Minimum Public Holders Rule ”). The Notice is only a notification of deficiency, not of imminent delisting, and has no current effect on the listing or trading of the Company’s securities on Na”

Belong Acquisition Corp. received a nasdaq deficiency notice notice regarding shareholders (rules 5550(a)(3)).

“March 27, 2023, Belong Acquisition Corp. (the “Company”) received a written notice (the “Notice”) from the Nasdaq Listing Qualifications Department of The Nasdaq Stock Market (“Nasdaq”) indicating that the Company was not in compliance with Listing Rule 5550(a)(3), which requires the Company to have at least 300 public holders for continued listing on the Nasdaq Capital Market (the “Minimum Public Holders Rule”). The Notice is only a notification of deficiency, not of imminent delisting, and has no current effect on the listing or trading of the Company’s securities on Nasdaq Capital Market. T”

Getaround, Inc received a nyse deficiency notice notice regarding minimum bid price (rules 802.01C).

“January 30, 2023 that it was not in compliance with Section 802.01C of the NYSE Listed Company Manual because the average closing price of the Company’s common stock was less than $1.00 over a consecutive 30 trading-day period. In connection with the January notice, the Company notified the NYSE that it intends to cure the stock price deficiency and to return to compliance with the NYSE continued listing standard with respect to the deficiency under Section 802.01C. The Company is currently within the six-month cure period following receipt of the January notice. In accordance with the NYSE Li”

Getaround, Inc received a nyse deficiency notice notice regarding market value (rules 802.01B).

“March 27, 2023, the Company received written notice from the New York Stock Exchange (the “NYSE”) that it is not in compliance with the continued listing standard set forth in Section 802.01B of the NYSE Listed Company Manual because the average global market capitalization of the Company over a consecutive 30 trading-day period was less than $50 million and, at the same time, its last reported stockholders’ equity was less than $50 million. As previously disclosed in the Company’s Current Report on Form 8-K filed with the Securities and Exchange Commission (“SEC”) on February 1, 2023, the Com”

Iris Acquisition Corp received a nasdaq deficiency notice notice regarding shareholders (rules 5550(a)(3)).

“March 30, 2023, the Company, received an additional written notice (the “Minimum Public Holders Notice”) from the Staff indicating that the Company was not in compliance with Listing Rule 5550(a)(3), which requires the Company to have at least 300 public holders for continued listing on the Nasdaq Capital Market (the “Minimum Public Holders Rule”). The Minimum Public Holders Notice is only a notification of deficiency, not of imminent delisting, and has no current effect on the listing or trading of the Company’s securities on the Nasdaq Capital Market. The Minimum Public Holders Notice states”

Iris Acquisition Corp received a nasdaq noncompliance notice notice regarding market value (rules 5810(c)(3)(C)).

“March 30, 2023, the Company, received an additional written notice (the “Minimum Public Holders Notice”) from the Staff indicating that the Company was not in compliance with Listing Rule 5550(a)(3), which requires the Company to have at least 300 public holders for continued listing on the Nasdaq Capital Market (the “Minimum Public Holders Rule”). The Minimum Public Holders Notice is only a notification of deficiency, not of imminent delisting, and has no current effect on the listing or trading of the Company’s securities on the Nasdaq Capital Market. The Minimum Public Holders Notice states”

SPRUCE POWER HOLDING CORP received a nyse deficiency notice notice regarding minimum bid price (rules 802.01C).

“March 28, 2023, Spruce Power Holding Corp. (the “Company”) was notified by the New York Stock Exchange (the “NYSE”) that it is not in compliance with Section 802.01C of the NYSE Listed Company Manual because the average closing price of the Company’s stock was less than $1.00 over a consecutive 30 day trading period. The Company will notify the NYSE on or prior to April 11, 2023 that it intends to cure the stock price deficiency and to return to compliance with the NYSE continued listing standard. The Company can regain compliance at any time within the six-month period following receipt of th”

SPRUCE POWER HOLDING CORP received a nyse deficiency notice notice regarding minimum bid price (rules 802.01C).

“March 28, 2023, Spruce Power Holding Corp. (the “Company”) was notified by the New York Stock Exchange (the “NYSE”) that it is not in compliance with Section 802.01C of the NYSE Listed Company Manual because the average closing price of the Company’s stock was less than $1.00 over a consecutive 30 day trading period. The Company will notify the NYSE on or prior to April 11, 2023 that it intends to cure the stock price deficiency and to return to compliance with the NYSE continued listing standard. The Company can regain compliance at any time within the six-month period following receipt of th”

Canoo Inc. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5450(a)(1)).

“March 27, 2023, Canoo, Inc. (the “ Company ”) received a written notice (the “ Notice ”) from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“ Nasdaq ”) indicating that, because the closing bid price for the Company’s common stock has fallen below $1.00 per share for 30 consecutive business days (February 9, 2023 through March 24, 2023), the Company no longer complies with the $1.00 Minimum Bid Price requirement set forth in Nasdaq Listing Rule 5450(a)(1) for continued listing on The Nasdaq Global Select Market (the “ Bid Price Requirement ”). The Notice has no immediate”

Harpoon Therapeutics, Inc. received a nasdaq deficiency notice notice regarding stockholders equity (rules 5450(b)(1)(A)).

“March 30, 2023, the Company received a notification letter (the “Stockholders’ Equity Notice”) from the Nasdaq Staff indicating that the Company’s stockholders’ equity of $5,399,000, as reported in its Annual Report on Form 10-K for the year ended December 31, 2022, does not satisfy Nasdaq’s continued listing requirement set forth in Nasdaq Listing Rule 5450(b)(1)(A), which requires companies listed on the Nasdaq Global Select Market to maintain a minimum of $10,000,000 in stockholders’ equity. The Stockholders’ Equity Notice also has no immediate effect on the listing of the Company’s common”

Harpoon Therapeutics, Inc. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5450(a)(1), 5810(c)(3)(A)).

“March 29, 2023, Harpoon Therapeutics, Inc., a Delaware corporation (the “Company”), received a notification letter (the “Bid Price Notice”) from the Listing Qualifications Staff (the “Nasdaq Staff”) of the Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that for the last 30 consecutive business days, the bid price of the Company’s common stock had closed below $1.00 per share, the minimum closing bid price required by the continued listing requirements of Nasdaq Listing Rule 5450(a)(1). The Bid Price Notice has no immediate effect on the listing of the Company’s common stock on the Na”

Knightscope, Inc. received a nasdaq deficiency notice notice regarding market value (rules 5450(b)(2)(A)).

“March 29, 2023, Knightscope, Inc. (the “Company”) received written notice (the “Notice”) from The Nasdaq Stock Market LLC (“Nasdaq”) indicating that the Company is no longer in compliance with the minimum Market Value of Listed Securities (“MVLS”) of $50,000,000 required for continued listing on The Nasdaq Global Market, as set forth in Nasdaq Listing Rule 5450(b)(2)(A) (the “MVLS Requirement”). The Notice has no effect at this time on the listing of the Company’s Class A common stock, which continues to trade on The Nasdaq Global Market under the symbol “KSCP”. In accordance with Nasdaq Listi”

T2 Biosystems, Inc. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2)).

“March 30, 2023, the Company received a letter (the “Nasdaq Staff Deficiency Letter”) from The Nasdaq Stock Market LLC (“Nasdaq”) indicating that, for the last thirty consecutive business days, the bid price for the Company’s common stock had closed below the minimum $1.00 per share requirement for continued listing on The Nasdaq Capital Market under Nasdaq Listing Rule 5550(a)(2). In accordance with Nasdaq Listing Rule 5810(c)(3)(A), the Company has been provided an initial period of 180 calendar days, or until September 26, 2023, to regain compliance. The letter states that the Nasdaq staff w”

22nd Century Group, Inc. received a nasdaq noncompliance notice notice regarding minimum bid price (rules 5550(a)(2), 5810(c)(3)(A)).

“March 31, 2023, 22nd Century Group, Inc. (the “Company”) received a deficiency letter from the Nasdaq Listing Qualifications Department indicating that for the last 30 consecutive business days the Company's common stock did not maintain a minimum closing bid price of $1.00 (“Minimum Bid Price Requirement”) per share for continued listing on The Nasdaq Capital Market pursuant to Nasdaq Listing Rule 5550(a)(2). The notification of noncompliance has no immediate effect on the listing or trading of the Company's common stock on the Nasdaq Capital Market. Under Nasdaq Listing Rule 5810(c)(3)(A)”

Capstone Energy Plus, Inc. received a nasdaq deficiency notice notice regarding market value (rules 5550(b)(2), 5550(b)(1), 5550(b)(3)).

“March 28, 2023, Capstone Green Energy Corporation (the “Company”) received a written notice (the “Notice”) from the Nasdaq Listing Qualifications Department of The Nasdaq Stock Market (“Nasdaq”) notifying the Company that for the last 30 consecutive business days, the Company’s Market Value of Listed Securities (“MVLS”) was below the minimum of $35 million required for continued listing on The Nasdaq Capital Market pursuant to Nasdaq Listing Rule 5550(b)(2). The Notice states that the Company also does not meet the requirements under Listing Rules 5550(b)(1) and 5550(b)(3), which set forth alt”

UNICO AMERICAN CORP received a nasdaq deficiency notice notice regarding market value (rules 5450(b)(1)(C), 5810(c)(3)(D)).

“September 22, 2022 indicating that the Company was not in compliance with the requirement of a minimum Market Value of Publicly Held Shares (“MVPHS”) of $5,000,000 for continued listing on the Nasdaq Global Market, as set forth in Nasdaq Listing Rule 5450(b)(1)(C). Nasdaq calculates MVPHS by subtracting from the total shares of common stock outstanding any shares held by officers, directors or any person who beneficially owns more than 10% of the total shares outstanding. In accordance with Nasdaq Listing Rule 5810(c)(3)(D), the Company was provided a period of 180 calendar days, or until Marc”

TENAX THERAPEUTICS, INC. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2)).

“March 29, 2023, Nasdaq Stock Market LLC (“Nasdaq”) notified Tenax Therapeutics, Inc. (the “Company”) that for the last 30 consecutive business days, the bid price for the Company’s common stock had closed below the minimum $1.00 per share requirement for continued inclusion on the Nasdaq Capital Market pursuant to Nasdaq Listing Rule 5550(a)(2) (the “Bid Price Rule”). In accordance with Nasdaq Listing Rule 5810(c)(3)(A), the Company has a compliance period of 180 calendar days, or until September 25, 2023, to regain compliance with the Bid Price Rule. If at any time before September 25, 2023”

Heartland Media Acquisition Corp. received a nyse noncompliance notice notice regarding audit committee (rules 303A.07(A)).

“March 30, 2023. The Company intends to regain compliance with NYSE Listed Company Manual Section 303A.07(A) promptly.”

Clever Leaves Holdings Inc. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2), 5810(c)(3)(A)).

“March 29, 2023, the Company received a second notice (the “Second Notice”) from Nasdaq indicating that, while the Company has not regained compliance with the Minimum Bid Price Requirement, the Staff has determined that the Company is eligible for an additional 180 calendar day period, or until September 25, 2023 (the “Second Compliance Period”), to regain compliance. According to the Second Notice, the Staff’s determination was based on (i) the Company meeting the continued listing requirement for market value of publicly held shares and all other applicable requirements for initial listing o”

Global Gas Corp received a nasdaq deficiency notice notice regarding market value (rules 5550(b)(2), 5810(c)(3)(C)).

“March 24, 2023, Dune Acquisition Corporation (the “Company”) received a notice from the staff of The Nasdaq Stock Market LLC (“Nasdaq”) indicating that, for the previous 30 consecutive business days, the minimum Market Value of Listed Securities (“MVLS”) for the Company’s Class A common stock was below the $35 million minimum MVLS requirement for continued listing on The Nasdaq Capital Market under Nasdaq Listing Rule 5550(b)(2) (the “MLVS Rule”). In accordance with Nasdaq Listing Rule 5810(c)(3)(C), the Company will have 180 calendar days, or until September 20, 2023, to regain compliance wit”

Cyxtera Technologies, Inc. received a nasdaq deficiency notice notice regarding audit committee (rules 5605).

“March 30, 2023, Cyxtera Technologies, Inc. (the “Company”) received a notice (the “Notice”) from The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that due to the resignations of Melissa Hathaway and Michelle Felman from the Company’s board of directors and audit committee, effective on March 28, 2023, the Company no longer complies with Nasdaq’s audit committee requirements as set forth in Nasdaq Listing Rules 5605, which requires an audit committee of at least three independent directors. The Notice has no immediate effect on the listing or trading of the Company’s Class A common”